Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer

Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer

Bibliographic Details
Main Author: Zheng Su
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420300624
id doaj-f12f6cd7a89b49e1a605826502a7f303
record_format Article
spelling doaj-f12f6cd7a89b49e1a605826502a7f3032020-11-25T03:16:28ZengElsevierContemporary Clinical Trials Communications2451-86542020-06-0118100578Different interpretations of the CheckMate-227 trial in non-small-cell lung cancerZheng Su0Deerfield Management, New York, USAhttp://www.sciencedirect.com/science/article/pii/S2451865420300624
collection DOAJ
language English
format Article
sources DOAJ
author Zheng Su
spellingShingle Zheng Su
Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
Contemporary Clinical Trials Communications
author_facet Zheng Su
author_sort Zheng Su
title Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_short Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_full Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_fullStr Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_full_unstemmed Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_sort different interpretations of the checkmate-227 trial in non-small-cell lung cancer
publisher Elsevier
series Contemporary Clinical Trials Communications
issn 2451-8654
publishDate 2020-06-01
url http://www.sciencedirect.com/science/article/pii/S2451865420300624
work_keys_str_mv AT zhengsu differentinterpretationsofthecheckmate227trialinnonsmallcelllungcancer
_version_ 1724635975598997504

Similar Items